Trial Condition(s):
Contraception, Ovulation inhibition, Contraceptives, Oral
Study to evaluate the ovulation inhibitory effect of Minisiston® (0.03 mg Ethinylestradiol and 0.125 mg Levonorgestrel)
Bayer Identifier:
91288
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
32
Trial Dates
Phase
4
Could I receive a placebo?
No
Products
Minisiston/Monostep (EE30/LNG, BAY86-4977)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
| Locations |
|---|
Trial Design
Monocenter, open-label, uncontrolled study to evaluate the ovulation inhibitory effect of Minisiston® (0.03 mg Ethinyl estradiol and 0.125 mg Levonorgestrel), applied for two treatment cycles to 30 female volunteers
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
